English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  A Transgenic Rat Model of Charcot-Marie-Tooth Disease

Sereda, M., Griffiths, I., Pühlhofer, A., Stewart, H., Rossner, M. J., Zimmermann, F., et al. (1996). A Transgenic Rat Model of Charcot-Marie-Tooth Disease. Neuron, 16(5), 1049-1060. doi:10.1016/S0896-6273(00)80128-2.

Item is

Files

show Files
hide Files
:
1-s2.0-S0896627300801282-main.pdf (Publisher version), 578KB
 
File Permalink:
-
Name:
1-s2.0-S0896627300801282-main.pdf
Description:
-
OA-Status:
Visibility:
Restricted ( Max Planck Society (every institute); )
MIME-Type / Checksum:
application/pdf
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show

Creators

show
hide
 Creators:
Sereda, Michael, Author
Griffiths, Ian, Author
Pühlhofer, Anja, Author
Stewart, Helen, Author
Rossner, Moritz J, Author
Zimmermann, Frank, Author
Magyar, Josef P, Author
Schneider, Armin, Author
Hund, Ernst, Author
Meinck, Hans-Michael, Author
Suter, Ueli, Author
Nave, Klaus-Armin1, Author           
Affiliations:
1Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society, ou_2173664              

Content

show
hide
Free keywords: -
 Abstract: Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy in humans and has been associated with a partial duplication of chromosome 17 (CMT type 1A). We have generated a transgenic rat model of this disease and provide experimental evidence that CMT1A is caused by increased expression of the gene for peripheral myelin protein-22 (PMP22, gas-3). PMP22-transgenic rats develop gait abnormalities caused by a peripheral hypomyelination, Schwann cell hypertrophy (onion bulb formation), and muscle weakness. Reduced nerve conduction velocities closely resemble recordings in human patients with CMT1A. When bred to homozygosity, transgenic animals completely fail to elaborate myelin. We anticipate that the CMT rat model will facilitate the identification of a cellular disease mechanism and serve in the evaluation of potential treatment strategies.

Details

show
hide
Language(s): eng - English
 Dates: 1996-05
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1016/S0896-6273(00)80128-2
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Neuron
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Cambridge, Mass. : Cell Press
Pages: - Volume / Issue: 16 (5) Sequence Number: - Start / End Page: 1049 - 1060 Identifier: ISSN: 0896-6273
CoNE: https://pure.mpg.de/cone/journals/resource/954925560565